News | November 11, 2021
Metropolis Healthcare PAT at Rs 58.26 cr in Q2FY22
Metropolis Healthcare has reported consolidated financial results for the period ended September 30, 2021
Metropolis Healthcare has reported consolidated financial results for the period ended September 30, 2021
The consideration for the acquisition is US $ 2.25 million
The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
Marksans Pharma has reported consolidated financial results for the period ended September 30, 2021
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The Board of Directors of Aurobindo Pharma have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The company has operations in North America, Asia, and Europe,
Subscribe To Our Newsletter & Stay Updated
